1.
Taeb M, Rahmani M, Sharifi L, Mirshafiey A. The Efficacy of Two Specific Toll-like Receptor 4 Antagonists (G2013 & M2000) in Clinical Inflammatory Disease. BJHMR [Internet]. 2024Jan.1 [cited 2024Nov.22];10(6):299-318. Available from: https://journals.scholarpublishing.org/index.php/JBEMi/article/view/14305